Parity with limb clonus. To our information, isolated pendular nystagmus as a sign of serotonin toxicity has never been described, nor has pendular nystagmus as a consequence of venlafaxine overdose. We suspect that our case represents an incomplete type (`forme fruste’) of the serotonin syndrome. The absence of other clinical characteristics of serotonin toxicity plus the regular investigations preluded a diagnosis of your complete serotonin syndrome, and the case would not have met either the Sternbach or Hunter criteria.1 2 Recognition of such incomplete forms is important, as theCASE PRESENTATIONA 54-year-old woman ingested 3 g of venlafaxine inside a modified-release preparation (40 tablets of 75 mg). She presented towards the emergency division 4 h right after ingestion, reporting blurred vision, dry mouth, nausea and vomiting. She denied co-ingestion of alcohol or any other substances, and was not on any typical medication. On examination, temperature was 36.four , pulse 101 bpm, blood pressure 142/89 mm Hg and oxygen saturation 98 on area air. She was calm, alert and oriented. She was not sweaty, shivery or tremulous. Muscle tone was typical. All reflexes had been markedly brisk but there was no limb clonus, and plantars were downgoing. Examination of eye MAO-A Accession movements demonstrated binocular horizontal pendular nystagmus using the eyes inside the key position (see video 1). Amplitude of nystagmus decreased with lateral gaze and was improved by central visual fixation. There was no ophthalmoplegia, and smooth pursuit and saccadic eye movements were preserved.To cite: Varatharaj A, Moran J. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-INVESTIGATIONSAn ECG showed sinus rhythm with correct axis deviation and ideal bundle branch block, with a corrected QT interval of 415 ms. Routine blood tests were inside normal limits, with a creatine kinase level of 132 units/L (range 0?45). ParacetamolVaratharaj A, et al. BMJ Case Rep 2014. doi:10.1136/bcr-2013-Findings that shed new light on the attainable pathogenesis of a disease or an adverse effectLearning points The serotonin syndrome happens consequently of drugs which improve synaptic serotonin, commonly selective serotonin reuptake inhibitors and serotonin orepinephrine reuptake inhibitor. In its total form, the syndrome presents with a triad of neuromuscular, autonomic and mental hyperexcitability. Incomplete forms may possibly occur and ought to be treated seriously, to prevent deterioration for the total syndrome. Ocular manifestations may possibly be the predominant sign of serotonin toxicitypeting interests None. Patient consent Obtained. Provenance and peer critique Not commissioned; externally peer reviewed.Video 1 Binocular horizontal pendular nystagmus, decreased in amplitude by lateral gaze, and Oxazolidinone drug enhanced by central visual fixation.serotonin syndrome just isn’t a side impact per se; it’s element from the clinical spectrum that results from agonism of central serotonin receptors, which is exploited for therapeutic effect by psychotropic medicines. Adverse consequences of enhanced serotonin levels could take place at therapeutic doses, and if overlooked, one particular could inadvertently precipitate the full-blown serotonin syndrome with an enhanced dose from the causative agent or addition of an additional provocative drug. Also, with all the use of modified-release preparations, the improvement of your total syndrome may take longer than anticipated, as well as the presence of incomplete toxicity may perhaps herald clinical deterioration.
NIH Pub.